Loading asset research
Q3 2026 earnings · Nov 6
Exicure Inc. Common Stock
XCURNasdaq · USD · StocksQuote as of · Exchange session not verified$1.23
-0.81%
Today
XCUR
Loading 1D prices…
Market cap
$8.1M
Volume
22.9K
52w high
$9.4852w low
$1.05Company profile
Exicure Inc. Common Stock
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
CHICAGO, IL, United States
Employees
1
Fiscal year end
1231
CIK
1698530
Session & valuation
Open$1.24
Previous close$1.24
Day high$1.28
Day low$1.22
30-day avg. volume39.8K
Outstanding shares6.5M
Diluted EPS-$0.79
Latest annual period
P/E (trailing)-1.56
P/E (forward)-1.60
Price / book3.74
Beta3.62
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ENSCEnsysce Biosciences Inc. Common Stock | $8.1M | $5.1M | -200.84% | -$3.98 | -3.61% | Unrated |
| TRAWTraws Pharma Inc. Common Stock | $8.3M | $2.8M | +328.67% | $0.82 | +12.00% | Hold |
| SNGXSoligenix Inc. Common Stock | $8.3M | $0.00 | — | -$2.14 | 0.00% | Unrated |
| IMNNImunon Inc. Common Stock | $7.7M | $0.00 | — | -$6.83 | -8.16% | Buy |
| CNSPCNS Pharmaceuticals Inc. Common Stock | $7.6M | $0.00 | — | -$35.75 | 0.00% | Buy |